Tower Research Capital »

Fulcrum Therapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $18k 1.9k 9.20
2025-06-30 $44k 6.4k 6.88
2025-03-31 $24k 8.3k 2.88
2024-12-31 $19k 4.0k 4.70
2024-09-30 $100k 28k 3.57
2024-06-30 $101k 16k 6.20
2024-03-31 $93k 9.9k 9.44
2023-09-30 $23k 5.2k 4.44
2023-06-30 $36k 11k 3.30
2023-03-31 $17k 5.9k 2.87
2022-12-31 $13k 1.8k 7.21
2022-09-30 $0 2.1k 0.00
2022-06-30 $28k 5.9k 4.79
2022-03-31 $25k 664 37.04
2021-12-31 $65k 3.6k 17.84
2021-09-30 $15k 534 28.09
2021-06-30 $17k 1.7k 10.28
2021-03-31 $11k 1.0k 10.31
2020-12-31 $61k 5.2k 11.73
2020-09-30 $107k 14k 7.89
2020-06-30 $45k 2.5k 18.21
2019-09-30 $6.4k 931 6.83